Background: Information is limited regarding the outcomes of patients with preexisting chronic kidney disease (CKD) who develop dialysis-requiring acute kidney injury. Methods: 131 adult patients with advanced CKD who received emergent hemodialysis from January to June in 2002 were recruited and monitored for all-cause mortality and end-stage renal disease until the end of 2007. Results: Among patients investigated, 21 (16%) were successfully withdrawn from acute hemodialysis after an average of 8 sessions of dialysis therapy (range: 1–44). Multivariate analysis revealed that larger kidney size (odds ratio, OR = 1.755, p = 0.018), lower predialysis creatinine (OR = 0.722, p = 0.002), and non-diabetes (OR = 0.271, p = 0.037) were predictors for withdrawal. After 5 years, all patients in the non-withdrawal group remained on chronic dialysis, whereas only 8/21 (38%) patients in the withdrawal group developed end-stage renal disease. Cox’s analysis showed that age (hazard ratio, HR = 1.043, p < 0.0001), prerenal azotemia (HR = 1.040, p = 0.002), and adjusted propensity score for assigning to dialysis withdrawal (HR = 6.819, p = 0.008) were associated with mortality. Withdrawal from acute dialysis was not related to long-term mortality (p = 0.34). Conclusions: Among the advanced CKD patients, predictors of the successful weaning from acute dialysis were non-diabetes, larger kidney size and lower serum creatinine levels. The strategy of removal from emergent dialysis was not related to long-term mortality.

Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH: Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 2002;40:275–279.
Lin YF, Ko WJ, Chu TS, et al: The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy. Am J Surg 2009;198:325–332.
Delannoy B, Floccard B, Thiolliere, et al: Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study. Intensive Care Med 2009;35:1907–1915.
Triverio PA, Martin PY, Romand J, Pugin J, Perneger T, Saudan P: Long-term prognosis after acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 2009;24:2186–2189.
Ishani A, Xue JL, Himmelfarb J, et al: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009;20:223–228.
Khosla N, Soroko SB, Chertow GM, et al: Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol 2009;4:1914–1919.
Schiffl H: Renal recovery after severe acute renal injury. Eur J Med Res 2008;13:552–556.
Wald R, Quinn RR, Luo J, et al: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009;302:1179–1185.
Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
Mehta RL, Pascual MT, Gruta CG, Zhuang S, Chertow GM: Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002;13:1350–1357.
Wu VC, Ko WJ, Chang HW, et al: Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med 2008;34:101–108.
Uchino S, Bellomo R, Morimatsu H, et al: Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 2009;37:2576–2580.
Bagshaw SM, Laupland KB, Doig CJ, et al: Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Critical Care 2005;9:R700–R709.
Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Go AS: Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 2009;4:891–898.
Schiffl H, Fischer R: Five-year outcomes of severe acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 2008;23:2235–2241.
Åhlström A, Tallgren M, Peltonen S, Räsänen P, Pettilä V: Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med 2005;31:1222–1228.
Metcalfe W, Simpson M, Khan IH, et al: Acute renal failure requiring renal replacement therapy: incidence and outcome. Q J Med 2002;95:579–583.
Cerdá J, Cerdá M, Kilcullen P, Prendergast J: In severe acute kidney injury, a higher serum creatinine is paradoxically associated with better patient survival. Nephrol Dial Transplant 2007;22:2781–2784.
Goodkin DA, Bragg-Gresham JL, Koenig KG, et al: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 2003;14:3270–3277.
Hall YN, Sugihara JG, Go AS, Chertow GM: Differential mortality and transplantation rates among Asians and pacific islanders with ESRD. J Am Soc Nephrol 2005;16:3711–3720.
Barbour SJ, Er L, Djurdjev O, Karim M, Levin A: Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian, and South Asian CKD patients. Nephrol Dial Transplant 2010;25:3663–3672.
Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813–818.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.